Larimar Therapeutics Inc (LRMR)
$2.47 -7.49% Close Oct 30, 2026 Live
Larimar Therapeutics stock today
Larimar Therapeutics closed at $2.47 on October 30, 2026, down 7.49% on the day. Over the past year it returned -38.9% with dividends reinvested, against +12.4% for the S&P 500. Its market value is $257 million.
$2.00$4.00$6.00
NovJan 2026MarMayJulSep
| Period | LRMR | S&P 500 (SPY) |
|---|---|---|
| 1 month | -22.7% | -0.9% |
| 3 months | -35.4% | +2.1% |
| Year to date | -35.2% | +11.7% |
| 1 year | -38.9% | +12.4% |
| 3 years | -15.4% | +88.5% |
| 5 years | -79.3% | +76.0% |
Key statistics
- Market value
- $257M
- 52-week range
- $1.99 to $5.95
- Next report
- Nov 5, 2026 (estimated)
About Larimar Therapeutics
Biopharmaceutical company developing treatments for genetic and rare diseases.
Sector: Health Care
More on Larimar Therapeutics
- Returns: what $1,000 became$1,000 ten years ago is $67.27 today
No forecast, no recommendation. This page describes Larimar Therapeutics Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.